Progranulin: A proangiogenic factor in visceral adipose tissue in tumoral and non-tumoral visceral pathology

xlomafota13 shared this article with you from Inoreader Progranulin: A proangiogenic factor in visceral adipose tissue in tumoral and non-tumoral visceral pathology Via Experimental and therapeutic medicine Exp Ther Med. 2021 Nov;22(5):1337. doi: 10.3892/etm.2021.10772. Epub 2021 Sep 22. ABSTRACT The connection between central obesity and the development and metastasis of various visceral tumors is largely accepted and one of the main causes seems to be the local synthesis of proangiogenic molecules. Progranulin (PRG), recently identified as an adipokine, is a novel pleiotropic growth factor acting on the proliferation and development of fast-growing epithelial cells, cancer cells, and also a proangiogenic factor whose expression is induced in activated endothelial cells. One of the molecules that seems to trigger the angiogenic activity of PRG is vascular endothelial growth factor (VEGF). Two groups of human subjects were considered and adipose tissue was processed for an immunohistochemical and morphometric study after surgery for abdominal tumoral or non-tumoral pathology. The presence of PRG in adipose pads of the omentum was analyzed and its association with VEGF, CD34 and collagen IV in tumoral and non-tumoral visceral pathology was examined. The results showed that PRG but not VEGF expression was upregulated in adipose tissue in tumoral visceral pathology. In conclusion, the involvement of the proangiogenic activity of PRG and VEGF in adipose tissue under tumor conditions may be dependent on the visceral tumor type. PMID:34630691 | PMC:PMC8495564 | DOI:10.3892/etm.2021.10772 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.